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Objectives: To analyse the mechanisms responsible for decreased susceptibility or resistance to carbapenems
in several enterobacterial isolates recovered in 2009–10 in Geneva University Hospitals, Switzerland.
Methods: PCR and sequencing were used to identify b-lactamases, 16S RNA methylases and plasmid-mediated
quinolone resistance genes. The transferable properties of the plasmids were analysed, as well as their plasmid
type. The strains were typed by multilocus sequence typing.
Results: Three patients were found to be positive for NDM-1-producing enterobacterial isolates (one with
Escherichia coli and Klebsiella pneumoniae, one with K. pneumoniae only and one with Proteus mirabilis),
where NDM-1 stands for New Delhi metallo-b-lactamase-1. The blaNDM-1 carbapenemase gene was detected
in all isolates in addition to genes encoding narrow-spectrum b-lactamases (TEM-1, SHV-11, OXA-1, OXA-9
and OXA-10), extended-spectrum b-lactamases (CTX-M-15, CMY-16 and CMY-30), ArmA and quinolone resist-
ance determinants (Qnr). The blaNDM-1 gene was located on conjugative IncA/C- or IncF-type plasmids.
Upstream of the blaNDM-1 gene, part of ISAba125, previously identified in NDM-1-negative Acinetobacter
baumannii, was found. Downstream of the blaNDM-1 gene, variable sequences were found.
Conclusions: This work constitutes the first identification of NDM-1 producers in Switzerland. Interestingly,
patients from whom these NDM-1-producing isolates were recovered had a link with the Indian subcontinent
or the Balkans.
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Introduction
The New Delhi metallo-b-lactamase-1 (NDM-1) is an Ambler
class B b-lactamase that confers resistance to all b-lactams
except aztreonam.1 Initially reported from Sweden in Klebsiella
pneumoniae and Escherichia coli from a patient transferred
from India,2 NDM-1-producing isolates have been particularly
associated with the UK, India and Pakistan;3 although, more
recently, such isolates as well as other species, including
Acinetobacter baumannii, have been reported from other parts
of the world.1 Recent data have suggested that the Balkans
and the Middle East might serve as secondary reservoirs of
NDM-1.4 – 9 Here, we report a retrospective study of enterobac-
teria exhibiting decreased carbapenem susceptibility that were
isolated in Geneva University Hospitals from March 2009 to
October 2010. Four isolates that were found to produce NDM-1
were subsequently subjected to detailed molecular analysis.
Materials and methods
Bacterial isolates and susceptibility testing
The enterobacterial isolates were identified by using a MicroFlex MALDI-
TOF/MS instrument using Biotyper 2 software (Bruker Daltonics, Fa¨llan-
den, Switzerland). The antibiotic susceptibilities of the isolates and their
transconjugants were determined first by the disc diffusion technique
on Mueller–Hinton agar plates with b-lactam and non-b-lactam
antibiotic-containing discs, and interpreted according to CLSI guide-
lines.10 Then, precise MIC values were determined by using Etest strips
(AB bioMe´rieux, Solna, Sweden). Azide-resistant E. coli J53 (Invitrogen,
Cergy-Pontoise, France) was used as the host in conjugation
experiments.11
PCR amplification and sequencing
Multiplex PCR approaches were used to detect different types of
b-lactamase genes,12,13 plasmid-mediated aminoglycoside resistance
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genes14 and plasmid-mediated quinolone resistance genes.15 PCR exper-
iments were performed to identify the upstream- and downstream-
located regions of the blaNDM-1 gene.
11 All amplified DNA fragments
were purified using the Qiaquick PCR purification kit (Qiagen, Courtaboeuf,
France). Both strands of the amplification products obtained were
sequenced using an ABI 3100 sequencer (Applied Biosystems, Foster
City, CA, USA). The nucleotide and deduced protein sequences were ana-
lysed with software available over the Internet at the National Center for
Biotechnology Information web site (www.ncbi.nlm.nih.gov).
Plasmid analysis
Conjugation assays were performed between clinical isolates as donors
and an azide-resistant E. coli J53 as the recipient strain, using a selection
based on ceftazidime (30 mg/L) and azide (100 mg/L).11 Plasmid DNAs
were extracted using the method of Kieser.16 Then, the plasmid incom-
patibility groups were determined by a PCR-based replicon typing
method, as described previously.17
Strain genotyping
Multilocus sequence typing (MLST) methods were used as previously
described for E. coli and K. pneumoniae isolates.18,19
Results and discussion
Twenty enterobacterial isolates with decreased susceptibility to
ertapenem were isolated at Geneva University Hospitals from
March 2009 to October 2010. Among them, four isolates were
found to be positive for blaNDM-1 by a preliminary PCR-based
analysis. They were a single E. coli (strain 5649), two K. pneumoniae
(strains 6642 and 6759) and a Proteus mirabilis (strain 7892).
E. coli 5649 and P. mirabilis 7892 were from rectal flora
(carriage), and K. pneumoniae 6642 and 6759 were from
urinary tract infections. E. coli 5649 and K. pneumoniae 6759
were from the same Serbian patient, K. pneumoniae 6642 was
from a patient previously hospitalized in India, and P. mirabilis
7892 was from a patient of Pakistani origin. These four entero-
bacterial isolates had either decreased susceptibility or were
fully resistant to the four carbapenems tested (Table 1). Of
note, NDM-1 production was not always associated with higher
MICs of ertapenem or imipenem (Table 1). A combined disc
test performed using 930 mg of EDTA and a disc of imipenem
with all the isolates as template gave positive results, suggesting
metallo-b-lactamase production. In addition, those isolates
were overall resistant to most antibiotics, including aminoglyco-
sides, fluoroquinolones, sulphonamides, trimethoprim and
rifampicin, with a few exceptions.
K. pneumoniae 6642 remained susceptible to tetracycline,
tigecycline, fosfomycin and colistin, K. pneumoniae 6759 was
susceptible to tigecycline, fosfomycin, colistin, ciprofloxacin and
amikacin, E. coli 5649 was susceptible to tigecycline, fosfomycin,
colistin, chloramphenicol and nitrofurantoin, and P. mirabilis
7892 was susceptible to tigecycline, fosfomycin, fluoroquino-
lones, trimethoprim and rifampicin.
As opposed to the findings of previous studies identifying
NDM-1 producers, no other carbapenemase genes (OXA-48 or
VIM types) were identified in these isolates.20 Downstream of
the blaNDM-1 gene, a putative bleomycin resistance gene was
identified in strain E. coli 5649. However, it was not detected in
the other isolates. Upstream of the blaNDM-1 gene, part of
ISAba125 was identified in all isolates. This ISAba125 element
has been previously identified in NDM-1-negative A. baumannii
isolates.21 This result further indicated that part of the
ISAba125 sequence is constantly present upstream of the
blaNDM-1 gene in Enterobacteriaceae. It is therefore likely that
this insertion sequence (IS) element may have played a role in
the mobilization of blaNDM-1, at least in the early processes of
its acquisition. It also suggests that the original dissemination
of the blaNDM-1 gene occurred in A. baumannii and that its
spread among Enterobacteriaceae might correspond to a
secondary event.
Transconjugants were obtained from all clinical strains, indi-
cating that the blaNDM-1 gene was always located on conjugative
plasmids. Two different plasmid scaffolds carrying blaNDM-1 were
identified, being IncF and IncA/C (Table 2). MICs of carbapenems
for those transconjugants were much lower than those obtained
for clinical strains, indicating that multiple carbapenem resist-
ance mechanisms are probably present in those clinical isolates
(Table 1). In addition to blaNDM-1, genes encoding TEM-1, OXA-1,
OXA-10 and SHV-11, the plasmid-mediated cephalosporinases
Table 1. MICs (mg/L) of carbapenems and other antibiotics for clinical isolates K. pneumoniae 6642 and 6759, E. coli 5649 and P. mirabilis 7892,
their transconjugants in E. coli J53 and E. coli J53
Strain IPM ETP MEM DOR GEN AMK Sulphonamides RIF TMP CIP
K. pneumoniae 6642 1 16 4 2 .32 .32 .32 .32 .32 .32
Tc6642 1 1 1 1 .32 .32 .32 .32 .32 0.5
K. pneumoniae 6759 8 .32 32 .32 16 4 .32 .32 .32 0.5
Tc6759 1 0.5 0.5 0.25 8 0.5 .32 .32 32 0.5
E. coli 5649 8 .32 16 8 .32 .32 .32 8 .32 .32
Tc5649 2 0.5 1 1 .32 .32 .32 4 .32 0.06
P. mirabilis 7892 2 0.5 0.5 0.5 .32 .32 .32 8 8 0.12
Tc7892 1 0.5 0.5 0.25 .32 .32 .32 4 0.25 0.06
E. coli J53 0.06 0.06 0.06 0.06 0.06 0.12 0.25 2 0.25 0.06
Tc, transconjugant; IPM, imipenem; ETP, ertapenem; MEM, meropenem; DOR, doripenem; GEN, gentamicin; AMK, amikacin; RIF, rifampicin; TMP,
trimethoprim; CIP, ciprofloxacin.
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OXA-9, CMY-16 and CMY-30 (derivatives of CMY-2), the extended-
spectrum b-lactamase CTX-M-15, SHV-28, the quinolone resist-
ance proteins QnrA6 and QnrB1, and the 16S rRNA methylase
ArmA and RmtA were identified (Table 2). Plasmids carrying
blaNDM-1 varied in size, being either of 130 or 150 kb. Noteworthy,
the three IncA/C-type plasmids were of the same size, but they
differed by the resistance genes they harboured (Table 2). The
identification of the blaNDM-1 gene on IncA/C- and IncF-type plas-
mids has been reported previously.3,22
MLST showed that K. pneumoniae 6642 and 6759 strains
belonged to two different sequence types (STs), namely ST147
and ST25. Interestingly, an ST147-type NDM-1-positive
K. pneumoniae has been recently identified from Iraq.4 E. coli
5649 belonged to ST410, previously identified in Norway for an
NDM-1-positive E. coli isolate recovered from a patient who
had been hospitalized in India.23
This study constitutes the first report of the identification of
NDM-1 producers in Switzerland. Only a single enterobacterial
isolate producing a carbapenemase has been reported from
Switzerland so far, corresponding to a KPC-2-producing
K. pneumoniae.24 Since Switzerland is one of the most open
countries to travellers, it is likely that the spread of such carbape-
nemase producers may be increasingly identified in the near
future and a detection strategy should be implemented there.
The origin of one of the patients (Serbia) further underlines
that the Balkan countries might be an additional source of
NDM-1 producers.8 The studied isolates were multidrug resistant,
and expressed clavulanic acid-inhibited extended-spectrum
b-lactamases, plasmid-mediated cephalosporinases and wide-
spectrum aminoglycoside resistance enzymes, further underlin-
ing the wide-spectrum activity of all resistance determinants
gathered among NDM-1 producers. Plasmids carrying the
blaNDM-1 gene did not co-harbour as many other resistances as
seen with other reported plasmids encoding NDM-1. This
suggests that the process of multidrug resistance in NDM-1 pro-
ducers is the result of successive acquisitions of resistance genes
rather than the acquisition of a single blaNDM-1-positive plasmid
carrying many resistance genes.
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